ADA and Miyoshi myopathy: Consistent with these findings, the protein levels of key ferroptosis markers, GPX4 and SCL7A11, decreased after ADA treatment, and again DFOM reversed this effect (Figure 3F), thus corroborating the induction of ferroptosis by ADA in MM cells.